CFG
TXMD icon

Citizens Financial Group’s TherapeuticsMD TXMD Stock Holding History

Citizens Financial Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-912
Closed -$17K – 461
2022
Q1 		$17K Buy
+912
New +$14.3K ﹤0.01% 441
2019
Q3 		– Sell
-20
Closed -$3K – 898
2019
Q2 		$3K Buy
+20
New +$3.58K ﹤0.01% 727

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Citizens Financial Group's TXMD Position: Q2 2022 in Review

Citizens Financial Group sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 912 shares — an estimated $17K sold.

Citizens Financial Group first reported a position in TXMD in Q2 2019 and held it in 2 quarters. The position peaked at $17K in Q1 2022. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Citizens Financial Group reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Citizens Financial Group sold 912 TherapeuticsMD shares in Q2 2022, an estimated $17K.
  • Citizens Financial Group first reported a position in TherapeuticsMD in Q2 2019 and held it in 2 quarters.
  • Citizens Financial Group's TherapeuticsMD position peaked at $17K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Citizens Financial Group's 13F filing for Q2 2022, filed 5 Aug 2022.